When Evommune went public late final yr, it mentioned information from a proof-of-concept trial of certainly one of its drug candidates for atopic dermatitis could be accessible within the first half of 2026. The outcomes are in, with the corporate reporting that the biologic drug met the primary goal of the trial, demonstrating the potential to supply a novel method […]